HomeKNSA • NASDAQ
add
Kiniksa Pharmaceuticals Ltd
Previous close
$23.96
Day range
$23.97 - $24.30
Year range
$14.12 - $27.92
Market cap
1.72B USD
Avg Volume
412.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 108.63M | 51.99% |
Operating expense | 66.41M | 25.44% |
Net income | -3.91M | -126.10% |
Net profit margin | -3.60 | -117.18% |
Earnings per share | -0.06 | -128.57% |
EBITDA | 313.00K | 112.26% |
Effective tax rate | 269.62% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 218.76M | 18.25% |
Total assets | 542.43M | 12.00% |
Total liabilities | 107.33M | 47.69% |
Total equity | 435.10M | — |
Shares outstanding | 71.24M | — |
Price to book | 3.92 | — |
Return on assets | -0.05% | — |
Return on capital | -0.07% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -3.91M | -126.10% |
Cash from operations | 5.17M | 238.07% |
Cash from investing | -46.80M | -231.70% |
Cash from financing | -178.00K | -212.66% |
Net change in cash | -41.81M | -230.86% |
Free cash flow | 2.77M | 1,666.43% |
About
Founded
2015
Website
Employees
297
